← Back to Search

Neuro-Music Therapy

Modified Heidelberg Model of Neuro-Music Therapy for Germ Cell Cancer

N/A
Waitlist Available
Led By Debra Burns, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the start of intervention until last subject completes intervention (i.e. up to 2 years)
Awards & highlights

Study Summary

This trial is testing a new therapy for tinnitus and cancer that involves music. They are testing how well patients can tolerate the therapy and follow the instructions.

Eligible Conditions
  • Relapsed Germ Cell Cancer
  • Tinnitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the start of intervention until last subject completes intervention (i.e. up to 2 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the start of intervention until last subject completes intervention (i.e. up to 2 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compliance and fidelity feasibility
Recruitment feasibility
Retention feasibility
Secondary outcome measures
Audiometric evaluation
Effects of intervention on anxiety determined by scores on the Impact of Events Scale
Effects of intervention on associated distress determined by scores on the Tinnitus Questionnaire
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Modified Heidelberg Model of Neuro-Music Therapy (mHNMT)Experimental Treatment1 Intervention
The mHNMT for Tinnitus program was modified based on participant feedback of the original HNMT. This study will include 6 sessions, 2 sessions a week including the following interventions: resonance training, music relaxation, Intonation Training and session review/homework.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,161 Total Patients Enrolled
Debra Burns, PhDPrincipal InvestigatorIndiana University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What goals is this medical study striving to accomplish?

"The primary assessment of this trial covers a period up to two years, and is focused on the success of recruitment. Secondary outcomes include an analysis of anxiety levels via the Impact Events Scale (0-4), severity in tinnitus observed on the Tinnitus Functional Index (1-10) as well as associated distress captured through the Tinnitus Questionnaire (0-82)."

Answered by AI

How many participants has this clinical trial recruited to date?

"Affirmative. According to the clinicaltrials.gov website, this medical experiment is actively seeking volunteers and was initially posted on December 2nd 2019 with its most recent update being June 8th 2022. At present, they need 15 patients at a single site for participation."

Answered by AI

Are there any eligibility requirements to join the current clinical trial?

"As evidenced on clinicaltrials.gov, this trial is currently accepting applicants. It was first advertised on December 2nd 2019 and has been revised as recently as June 8th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Kentucky
How old are they?
18 - 65
What site did they apply to?
Indiana University Melvin & Bren Simon Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
~0 spots leftby Apr 2025